XML 27 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Non-Guarantor Subsidiary Financial Information Level 3 (Tables)
9 Months Ended
Sep. 30, 2014
Guarantor - Condensed Consolidating Statements of Operations [Abstract]  
Condensed Consolidating Balance Sheet [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
SEPTEMBER 30, 2014
CONDENSED CONSOLIDATING BALANCE SHEET (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0, $0 and $16, respectively)
$
9

 
$
2

 
$

 
$
106

 
$

 
$
117

Short-term investments

 

 

 
10

 

 
10

Accounts receivable, net
220

 

 
2

 
503

 

 
725

Intercompany accounts receivable
87

 
103

 
1

 
82

 
(273
)
 

Intercompany loans receivable - current portion
248

 

 

 
29

 
(277
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
115

 

 

 
186

 

 
301

Raw materials and supplies
58

 

 

 
77

 

 
135

Other current assets
29

 

 

 
49

 

 
78

Total current assets
766

 
105

 
3

 
1,042

 
(550
)
 
1,366

Investment in unconsolidated entities
339

 

 
33

 
30

 
(353
)
 
49

Deferred income taxes

 

 

 
18

 

 
18

Other assets, net
21

 
56

 
1

 
50

 

 
128

Intercompany loans receivable
1,083

 
3,364

 
28

 
13

 
(4,488
)
 

Property and equipment, net
532

 

 

 
527

 

 
1,059

Goodwill
66

 

 

 
56

 

 
122

Other intangible assets, net
58

 

 

 
27

 

 
85

Total assets
$
2,865

 
$
3,525

 
$
65

 
$
1,763

 
$
(5,391
)
 
$
2,827

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
166

 
$

 
$

 
$
338

 
$

 
$
504

Intercompany accounts payable
185

 
4

 

 
84

 
(273
)
 

Debt payable within one year
27

 

 

 
101

 

 
128

Intercompany loans payable within one year
29

 

 

 
248

 
(277
)
 

Interest payable
4

 
85

 

 
1

 

 
90

Income taxes payable
5

 

 

 
13

 

 
18

Accrued payroll and incentive compensation
22

 

 

 
41

 

 
63

Other current liabilities
66

 

 

 
52

 

 
118

Total current liabilities
504

 
89

 

 
878

 
(550
)
 
921

Long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
353

 
3,326

 

 
27

 

 
3,706

Intercompany loans payable
3,398

 

 
6

 
1,084

 
(4,488
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
641

 

 
244

 

 
(885
)
 

Long-term pension and post employment benefit obligations
39

 

 

 
170

 

 
209

Deferred income taxes
7

 
2

 

 
12

 

 
21

Other long-term liabilities
106

 

 

 
48

 

 
154

Total liabilities
5,048

 
3,417

 
250

 
2,219

 
(5,923
)
 
5,011

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(2,183
)
 
108

 
(185
)
 
(455
)
 
532

 
(2,183
)
Noncontrolling interest

 

 

 
(1
)
 

 
(1
)
Total (deficit) equity
(2,183
)
 
108

 
(185
)
 
(456
)
 
532

 
(2,184
)
Total liabilities and (deficit) equity
$
2,865

 
$
3,525

 
$
65

 
$
1,763

 
$
(5,391
)
 
$
2,827

MOMENTIVE SPECIALTY CHEMICALS INC.
DECEMBER 31, 2013
CONDENSED CONSOLIDATING BALANCE SHEET
  
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents (including restricted cash of $0, $0 and $14, respectively)
$
165

 
$
5

 
$

 
$
223

 
$

 
$
393

Short-term investments

 

 

 
7

 

 
7

Accounts receivable, net
179

 

 

 
422

 

 
601

Intercompany accounts receivable
190

 
89

 

 
374

 
(653
)
 

Intercompany loans receivable - current portion
216

 

 

 
278

 
(494
)
 

Inventories:
 
 
 
 
 
 
 
 
 
 
 
Finished and in-process goods
105

 

 

 
152

 

 
257

Raw materials and supplies
38

 

 

 
65

 

 
103

Other current assets
27

 

 

 
45

 

 
72

Total current assets
920

 
94

 

 
1,566

 
(1,147
)
 
1,433

Investment in unconsolidated entities
351

 

 
29

 
28

 
(363
)
 
45

Deferred income taxes

 

 

 
21

 

 
21

Other assets, net
31

 
59

 
2

 
42

 

 
134

Intercompany loans receivable
1,251

 
3,355

 
29

 
4,221

 
(8,856
)
 

Property and equipment, net
491

 

 

 
556

 

 
1,047

Goodwill
52

 

 

 
60

 

 
112

Other intangible assets, net
47

 

 

 
35

 

 
82

Total assets
$
3,143

 
$
3,508

 
$
60

 
$
6,529

 
$
(10,366
)
 
$
2,874

Liabilities and (Deficit) Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
165

 
$

 
$

 
$
318

 
$

 
$
483

Intercompany accounts payable
130

 

 

 
523

 
(653
)
 

Debt payable within one year
20

 

 

 
89

 

 
109

Intercompany loans payable within one year
173

 

 

 
321

 
(494
)
 

Interest payable
10

 
72

 

 
1

 

 
83

Income taxes payable
4

 

 

 
8

 

 
12

Accrued payroll and incentive compensation
19

 

 

 
28

 

 
47

Other current liabilities
65

 

 

 
62

 

 
127

Total current liabilities
586

 
72

 

 
1,350

 
(1,147
)
 
861

Long term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
309

 
3,326

 

 
30

 

 
3,665

Intercompany loans payable
3,388

 

 
7

 
5,461

 
(8,856
)
 

Accumulated losses of unconsolidated subsidiaries in excess of investment
762

 

 
261

 

 
(1,023
)
 

Long-term pension and post employment benefit obligations
50

 

 

 
184

 

 
234

Deferred income taxes
7

 
2

 

 
12

 

 
21

Other long-term liabilities
110

 
6

 

 
47

 

 
163

Total liabilities
5,212

 
3,406

 
268

 
7,084

 
(11,026
)
 
4,944

Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity
(2,069
)
 
102

 
(208
)
 
(554
)
 
660

 
(2,069
)
Noncontrolling interest

 

 

 
(1
)
 

 
(1
)
Total (deficit) equity
(2,069
)
 
102

 
(208
)
 
(555
)
 
660

 
(2,070
)
Total liabilities and (deficit) equity
$
3,143

 
$
3,508

 
$
60

 
$
6,529

 
$
(10,366
)
 
$
2,874

Condensed Consolidating Statement of Operations [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED SEPTEMBER 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
597

 
$

 
$

 
$
816

 
$
(66
)
 
$
1,347

Cost of sales
531

 

 

 
723

 
(66
)
 
1,188

Gross profit
66

 

 

 
93

 

 
159

Selling, general and administrative expense
24

 

 

 
60

 

 
84

Business realignment costs
4

 

 

 
2

 

 
6

Other operating expense (income), net
1

 

 
(1
)
 
4

 

 
4

Operating income
37

 

 
1

 
27

 

 
65

Interest expense, net
8

 
68

 

 
1

 

 
77

Intercompany interest expense (income), net
45

 
(68
)
 

 
23

 

 

Other non-operating expense (income), net
62

 

 

 
(44
)
 

 
18

(Loss) income before income tax and earnings from unconsolidated entities
(78
)
 

 
1

 
47

 

 
(30
)
Income tax (benefit) expense
(1
)
 
(6
)
 

 
9

 

 
2

(Loss) income before earnings from unconsolidated entities
(77
)
 
6

 
1

 
38

 

 
(32
)
Earnings from unconsolidated entities, net of taxes
49

 

 
26

 
2

 
(73
)
 
4

Net (loss) income
$
(28
)
 
$
6

 
$
27

 
$
40

 
$
(73
)
 
$
(28
)
Comprehensive (loss) income
$
(67
)
 
$
7

 
$
26

 
$
35

 
$
(68
)
 
$
(67
)
MOMENTIVE SPECIALTY CHEMICALS INC.
THREE MONTHS ENDED SEPTEMBER 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
553

 
$

 
$

 
$
748

 
$
(52
)
 
$
1,249

Cost of sales
475

 

 

 
669

 
(52
)
 
1,092

Gross profit
78

 

 

 
79

 

 
157

Selling, general and administrative expense
28

 

 

 
65

 

 
93

Business realignment costs
2

 

 

 
2

 

 
4

Other operating (income) expense, net

 

 
(1
)
 
3

 

 
2

Operating income
48

 

 
1

 
9

 

 
58

Interest expense, net
7

 
68

 

 
2

 

 
77

Intercompany interest expense (income), net
31

 
(69
)
 

 
38

 

 

Other non-operating (income) expense, net
(25
)
 

 

 
23

 

 
(2
)
Income (loss) before income tax and losses from unconsolidated entities
35

 
1

 
1

 
(54
)
 

 
(17
)
Income tax expense (benefit)
61

 

 

 
(4
)
 

 
57

(Loss) income before losses from unconsolidated entities
(26
)
 
1

 
1

 
(50
)
 

 
(74
)
Losses from unconsolidated entities, net of taxes
(50
)
 

 
(32
)
 

 
80

 
(2
)
Net (loss) income
$
(76
)
 
$
1

 
$
(31
)
 
$
(50
)
 
$
80

 
$
(76
)
Comprehensive (loss) income
$
(48
)
 
$
1

 
$
(31
)
 
$
(40
)
 
$
70

 
$
(48
)
MOMENTIVE SPECIALTY CHEMICALS INC.
NINE MONTHS ENDED SEPTEMBER 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)

 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,770

 
$

 
$

 
$
2,392

 
$
(185
)
 
$
3,977

Cost of sales
1,560

 

 

 
2,116

 
(185
)
 
3,491

Gross profit
210

 

 

 
276

 

 
486

Selling, general and administrative expense
79

 

 

 
196

 

 
275

Business realignment costs
19

 

 

 
5

 

 
24

Other operating expense (income), net
4

 

 
(1
)
 
4

 

 
7

Operating income
108

 

 
1

 
71

 

 
180

Interest expense, net
23

 
202

 

 
5

 

 
230

Intercompany interest expense (income), net
132

 
(204
)
 

 
72

 

 

Other non-operating expense (income), net
67

 

 

 
(44
)
 

 
23

(Loss) income before income tax and earnings from unconsolidated entities
(114
)
 
2

 
1

 
38

 

 
(73
)
Income tax (benefit) expense
(2
)
 
(6
)
 

 
31

 

 
23

(Loss) income before earnings from unconsolidated entities
(112
)
 
8

 
1

 
7

 

 
(96
)
Earnings from unconsolidated entities, net of taxes
30

 

 
30

 
4

 
(50
)
 
14

Net (loss) income
$
(82
)
 
$
8

 
$
31

 
$
11

 
$
(50
)
 
$
(82
)
Comprehensive (loss) income
$
(117
)
 
$
8

 
$
31

 
$
10

 
$
(49
)
 
$
(117
)

MOMENTIVE SPECIALTY CHEMICALS INC.
NINE MONTHS ENDED SEPTEMBER 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS (Unaudited)
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$
1,662

 
$

 
$

 
$
2,185

 
$
(156
)
 
$
3,691

Cost of sales
1,424

 

 

 
1,971

 
(156
)
 
3,239

Gross profit
238

 

 

 
214

 

 
452

Selling, general and administrative expense
85

 

 

 
189

 

 
274

Asset impairments

 

 

 
7

 

 
7

Business realignment costs
8

 

 

 
7

 

 
15

Other operating expense (income), net
3

 
(4
)
 
(1
)
 
6

 

 
4

Operating income
142

 
4

 
1

 
5

 

 
152

Interest expense, net
25

 
196

 

 
6

 

 
227

Intercompany interest expense (income), net
122

 
(199
)
 

 
77

 

 

Loss on extinguishment of debt
2

 

 

 
4

 

 
6

Other non-operating (income) expense, net
(18
)
 

 

 
19

 

 
1

Income (loss) before income tax and (losses) earnings from unconsolidated entities
11

 
7

 
1

 
(101
)
 

 
(82
)
Income tax expense
19

 
1

 

 
11

 

 
31

(Loss) income before (losses) earnings from unconsolidated entities
(8
)
 
6

 
1

 
(112
)
 

 
(113
)
(Losses) earnings from unconsolidated entities, net of taxes
(100
)
 

 
(55
)
 
2

 
158

 
5

Net (loss) income
$
(108
)
 
$
6

 
$
(54
)
 
$
(110
)
 
$
158

 
$
(108
)
Comprehensive (loss) income
$
(108
)
 
$
6

 
$
(54
)
 
$
(118
)
 
$
166

 
$
(108
)
Condensed Consolidating Statement of Cash Flows [Table Text Block]
MOMENTIVE SPECIALTY CHEMICALS INC.
NINE MONTHS ENDED SEPTEMBER 30, 2013
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows (used in) provided by operating activities
$
(33
)
 
$
1

 
$
17

 
$
90

 
$
(98
)
 
$
(23
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(49
)
 

 

 
(47
)
 

 
(96
)
Capitalized interest

 

 

 
(1
)
 

 
(1
)
Purchases of securities, net

 

 

 
(1
)
 

 
(1
)
Capital contribution to subsidiary
(15
)
 

 
(10
)
 

 
25

 

Change in restricted cash

 

 

 
4

 

 
4

Proceeds from sale of assets

 

 

 
1

 

 
1

Return of capital from subsidiary from sales of accounts receivable
126

(a)

 

 

 
(126
)
 

Investment in unconsolidated affiliates, net

 

 

 
(13
)
 

 
(13
)
 
62

 

 
(10
)
 
(57
)
 
(101
)
 
(106
)
Cash flows (used in) provided by financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt borrowings

 

 

 
16

 

 
16

Borrowings of long-term debt

 
1,108

 

 
20

 

 
1,128

Repayments of long-term debt
(545
)
 
(120
)
 

 
(380
)
 

 
(1,045
)
Net intercompany loan borrowings (repayments)
437

 
(882
)
 
(2
)
 
447

 

 

Long-term debt and credit facility financing fees
(13
)
 
(24
)
 

 

 

 
(37
)
Capital contribution from parent

 

 
10

 
15

 
(25
)
 

Common stock dividends paid

 
(83
)
 
(15
)
 

 
98

 

Return of capital to parent from sales of accounts receivable

 

 

 
(126
)
(a)
126

 

 
(121
)
 
(1
)
 
(7
)
 
(8
)
 
199

 
62

Effect of exchange rates on cash and cash equivalents

 

 

 
(2
)
 

 
(2
)
(Decrease) increase in cash and cash equivalents
(92
)
 

 

 
23

 

 
(69
)
Cash and cash equivalents (unrestricted) at beginning of period
276

 

 

 
125

 

 
401

Cash and cash equivalents (unrestricted) at end of period
$
184

 
$

 
$

 
$
148

 
$

 
$
332

MOMENTIVE SPECIALTY CHEMICALS INC.
NINE MONTHS ENDED SEPTEMBER 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Unaudited)
 
 
Momentive
Specialty
Chemicals
Inc.
 
Subsidiary
Issuers
 
Combined
Subsidiary
Guarantors
 
Combined
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Cash flows (used in) provided by operating activities
$
(349
)
 
$
(3
)
 
$
9

 
$
220

 
$
(9
)
 
$
(132
)
Cash flows provided by (used in) investing activities
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(74
)
 

 

 
(59
)
 

 
(133
)
Acquisition of businesses
(52
)
 

 

 
(12
)
 

 
(64
)
Purchases of securities, net

 

 

 
(4
)
 

 
(4
)
Change in restricted cash

 

 

 
(2
)
 

 
(2
)
Disbursement of affiliated loan

 

 

 
(50
)
 

 
(50
)
Repayment of affiliated loan

 

 

 
50

 

 
50

Capital contribution to subsidiary
(16
)
 

 
(10
)
 

 
26

 

Investment in unconsolidated affiliates, net

 

 

 
(2
)
 

 
(2
)
Return of capital from subsidiary from sales of accounts receivable
272

(a)

 

 

 
(272
)
 

 
130

 

 
(10
)
 
(79
)
 
(246
)
 
(205
)
Cash flows provided by (used in) financing activities
 
 
 
 
 
 
 
 
 
 
 
Net short-term debt borrowings
8

 

 

 
17

 

 
25

Borrowings of long-term debt
155

 

 

 
58

 

 
213

Repayments of long-term debt
(110
)
 

 

 
(64
)
 

 
(174
)
Net intercompany loan borrowings (repayments)
10

 

 

 
(10
)
 

 

Capital contribution from parent

 

 
10

 
16

 
(26
)
 

Common stock dividends paid

 

 
(9
)
 

 
9

 

Return of capital to parent from sales of accounts receivable

 

 

 
(272
)
(a)
272

 

 
63

 

 
1

 
(255
)
 
255

 
64

Effect of exchange rates on cash and cash equivalents

 

 

 
(5
)
 

 
(5
)
Decrease in cash and cash equivalents
(156
)
 
(3
)
 

 
(119
)
 

 
(278
)
Cash and cash equivalents (unrestricted) at beginning of period
165

 
5

 

 
209

 

 
379

Cash and cash equivalents (unrestricted) at end of period
$
9

 
$
2

 
$

 
$
90

 
$

 
$
101

(a)
During the nine months ended September 30, 2014, Momentive Specialty Chemicals Inc. contributed receivables of $272 to a non-guarantor subsidiary as capital contributions, resulting in a non-cash transaction. During the nine months ended September 30, 2014, the non-guarantor subsidiary sold the contributed receivables to certain banks under various supplier financing agreements. The cash proceeds were returned to Momentive Specialty Chemicals Inc. by the non-guarantor subsidiary as a return of capital. The sale of receivables has been included within cash flows from operating activities on the Combined non-guarantor subsidiaries. The return of the cash proceeds from the sale of receivables has been included as a financing outflow and an investing inflow on the Combined Non-Guarantor Subsidiaries and Momentive Specialty Chemicals Inc., respectively.